FierceBiotech9d
Glucotrack’s 3-year diabetes sensor implant clears initial human safety trial
Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...
GlobalData on MSN10d
Glucotrack hits trial success for direct blood measuring CGM
Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...
Business Insider10d
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Goode, PhD, President & Chief Executive Officer of Glucotrack. “With these positive results ... with no procedure or device related serious adverse events reported from implant through seven days post ...
Nasdaq10d
Glucotrack Completes First Human Trial For Implantable Continuous Blood Glucose Monitor
(RTTNews) - Glucotrack, Inc. (GCTK), a medical technology ... This milestone study, which aimed to evaluate the safety of the implant, use, and removal of the CBGM sensor lead, confirms the ...
Finanznachrichten10d
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Goode, PhD, President & Chief Executive Officer of Glucotrack. "With these positive results ... with no procedure or device related serious adverse events reported from implant through seven days post ...
Morningstar10d
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Goode, PhD, President & Chief Executive Officer of Glucotrack ... or device related serious adverse events reported from implant through seven days post-removal of the CBGM sensor lead.